Covance boosts Phase I capacity with SPC buy
Covance has expanded its clinical pharmacology capabilities via the purchase of Swiss Pharma Contract, a 50-bed clinical research company based in Basel.
Archives for March 18, 2009
EMEA reflects on non-EU clinical data
The European Medicines Agency (EMEA) has called for “in-depth, prospective analysis of potential ethnic factors” when considering whether clinical trials conducted outside the EU will be acceptable in marketing authorisation applications.
CIT adds MAb testing as demand rises
CIT is launching a tissue cross-reactivity service, which will allow biotechs to screen monoclonal antibody-based therapies for tissue binding, in response to rising market demand.
SCS welcomes StemCells deal in light of US rule change
Alastair Riddell, CEO of UK firm Stem Cell Sciences (SCS), says the US governments’ reversal of the ban on federally funded stem cell research “opens up a market that was inhibited, restrained and impeded under the Bush administration.”
MDS earnings blitzed by slumping revenues
The tough operating climate facing contract research organisations (CROs) seems to have hit Canada’s MDS particularly hard, with a 13 per cent drop in fiscal first quarter revenues to $257m.